144 related articles for article (PubMed ID: 1574528)
21. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
[TBL] [Abstract][Full Text] [Related]
22. Effects of atropine and azaprophen on matching and detection in rhesus monkeys.
Genovese RF; Elsmore TF
Pharmacol Biochem Behav; 1989 Feb; 32(2):495-8. PubMed ID: 2727010
[TBL] [Abstract][Full Text] [Related]
23. Effects of selected muscarinic cholinergic antagonists on [3H]acetylcholine release from rat hippocampal slices.
Pohorecki R; Head R; Domino EF
J Pharmacol Exp Ther; 1988 Jan; 244(1):213-7. PubMed ID: 3335998
[TBL] [Abstract][Full Text] [Related]
24. The action of atropine, benactyzine, and scopolamine upon fixed-interval and fixed-ratio behavior.
BOREN JJ; NAVARRO AP
J Exp Anal Behav; 1959 Apr; 2(2):107-15. PubMed ID: 13802768
[No Abstract] [Full Text] [Related]
25. Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats.
Li SM; Newman AH; Katz JL
J Pharmacol Exp Ther; 2005 Jun; 313(3):1223-30. PubMed ID: 15743929
[TBL] [Abstract][Full Text] [Related]
26. Anticonvulsant actions of anticholinergic drugs in soman poisoning.
Capacio BR; Shih TM
Epilepsia; 1991; 32(5):604-15. PubMed ID: 1915166
[TBL] [Abstract][Full Text] [Related]
27. Discriminable effects of antimuscarinics: dose response and substitution test studies.
Overton DA
Pharmacol Biochem Behav; 1977 Jun; 6(6):659-66. PubMed ID: 263548
[TBL] [Abstract][Full Text] [Related]
28. Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M.
Chintoh A; Fulton J; Koziel N; Aziz M; Sud M; Yeomans JS
Pharmacol Biochem Behav; 2003 Aug; 76(1):53-61. PubMed ID: 13679217
[TBL] [Abstract][Full Text] [Related]
29. Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.
Nilsson BM; Vargas HM; Ringdahl B; Hacksell U
J Med Chem; 1992 Jan; 35(2):285-94. PubMed ID: 1732545
[TBL] [Abstract][Full Text] [Related]
30. Chronic exercise produces tolerance to muscarinic antagonists in rats.
McMaster SB; Carney JM
Pharmacol Biochem Behav; 1986 Apr; 24(4):865-8. PubMed ID: 3714778
[TBL] [Abstract][Full Text] [Related]
31. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
Hollingsworth PJ; Smith CB
Eur J Pharmacol; 1989 Sep; 168(2):159-67. PubMed ID: 2558024
[TBL] [Abstract][Full Text] [Related]
32. [Effect of biotransformation on the receptor selectivity of muscarinic antagonists in vivo].
Kosmachev AB; Titkova TA; Fil'ko OA; Libman NM
Eksp Klin Farmakol; 2000; 63(4):13-6. PubMed ID: 11022298
[TBL] [Abstract][Full Text] [Related]
33. Muscarinic receptor blockade increases basal acetylcholine release from striatal slices.
Dolezal V; Wecker L
J Pharmacol Exp Ther; 1990 Feb; 252(2):739-43. PubMed ID: 2313598
[TBL] [Abstract][Full Text] [Related]
34. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
35. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
Acri JB; Siedleck BK; Witkin JM
J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory activities of several atropine-like drugs on the contraction of the digestive system and urinary bladder induced by the parasympathetic nerve stimulation in the dog].
Kumada S; Otsuka M
Nihon Yakurigaku Zasshi; 1970 Sep; 66(5):600-5. PubMed ID: 5529897
[No Abstract] [Full Text] [Related]
37. Characterization of the scopolamine stimulus in rats.
Jung M; Perio A; Worms P; Biziere K
Psychopharmacology (Berl); 1988; 95(2):195-9. PubMed ID: 3137597
[TBL] [Abstract][Full Text] [Related]
38. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
Moss S; Sharott A; Goodhead LH; Mitchell SN
Eur J Pharmacol; 2003 Jan; 460(2-3):117-25. PubMed ID: 12559371
[TBL] [Abstract][Full Text] [Related]
39. ["Sensitizing" and "desensitizing" effect of atropine, bete, and amizil on the anticonvulsant activity of pentafen and tropacin].
LISUNKIN IuI
Biull Eksp Biol Med; 1962 Sep; 54():69-73. PubMed ID: 13930947
[No Abstract] [Full Text] [Related]
40. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
Newman AH; Robarge MJ; Howard IM; Wittkopp SL; George C; Kopajtic T; Izenwasser S; Katz JL
J Med Chem; 2001 Feb; 44(4):633-40. PubMed ID: 11170654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
